Related references
Note: Only part of the references are listed.Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy
Sanaz Samiei et al.
ANNALS OF SURGERY (2020)
Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS)
Alison Price et al.
BREAST JOURNAL (2020)
Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
Bryan J. Pyfer et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
Mara A. Piltin et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Jennifer L. Miller-Ocuin et al.
AMERICAN SURGEON (2020)
Avoiding Axillary Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy in Breast Cancer: Rationale for the Prospective, Multicentric EUBREAST-01 Trial
Toralf Reimer et al.
CANCERS (2020)
Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes
Erin Ferrigni et al.
CLINICAL BREAST CANCER (2019)
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study
Jean-Marc Classe et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy
Yusuke Watanabe et al.
BREAST CANCER (2018)
Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery?
Toralf Reimer et al.
BREAST CARE (2018)
Breast Cancer, Version 4.2017 Clinical Practice Guidelines in Oncology
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2018)
Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy
Alison U. Barron et al.
JAMA SURGERY (2018)
Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer
S. R. Tee et al.
BRITISH JOURNAL OF SURGERY (2018)
Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt
Laura S. Dominici et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement
Todd M. Tuttle et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery
Audree B. Tadros et al.
JAMA SURGERY (2017)
Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy
Hiroko Nogi et al.
CLINICAL BREAST CANCER (2017)
Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
Anees B. Chagpar et al.
AMERICAN JOURNAL OF SURGERY (2017)
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer
Anees B. Chagpar et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Selective Use of Sentinel Lymph Node Surgery in Patients Undergoing Prophylactic Mastectomy Using Intraoperative Pathology
Brittany L. Murphy et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study
Thiemo J. A. van Nijnatten et al.
CLINICAL BREAST CANCER (2017)
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
Jana de Boniface et al.
BMC CANCER (2017)
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial
A. Savolt et al.
EJSO (2017)
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients
Hiba El Hage Chehade et al.
AMERICAN JOURNAL OF SURGERY (2016)
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial
Armando E. Giuliano et al.
ANNALS OF SURGERY (2016)
Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes
Anita Mamtani et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
Melissa Pilewskie et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes
Emilia J. Diego et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes
Corrado Tinterri et al.
BREAST (2016)
Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment
V. Galimberti et al.
EJSO (2016)
Tumor characteristics and therapy of elderly patients with breast cancer
A. -M. Grumpelt et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
Vivianne Freitas et al.
CANCER MEDICINE (2016)
POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases
A. Goyal et al.
CLINICAL ONCOLOGY (2015)
Variations in the management of the axilla in screen-detected Ductal Carcinoma In Situ: Evidence from the UK NHS Breast Screening Programme audit of screen detected DCIS
S. Nicholson et al.
EJSO (2015)
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
Jean-Francois Boileau et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Findings From the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial
Judy C. Boughey et al.
ANNALS OF SURGERY (2014)
Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-Year results of trial and out-trial patients
G. Martelli et al.
EJSO (2014)
Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011
Allison W. Kurian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker et al.
LANCET ONCOLOGY (2014)
Complete Axillary Lymph Node Dissection Versus Clinical Follow-up in Breast Cancer Patients with Sentinel Node Micrometastasis: Final Results from the Multicenter Clinical Trial AATRM 048/13/2000
Montserrat Sola et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial
Judy C. Boughey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Kevin S. Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti et al.
LANCET ONCOLOGY (2013)
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
Thorsten Kuehn et al.
LANCET ONCOLOGY (2013)
Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer
Savolt Akos et al.
ORVOSI HETILAP (2013)
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
Armando E. Giuliano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer
Laura S. Dominici et al.
CANCER (2010)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag et al.
LANCET ONCOLOGY (2010)
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
Armando E. Giuliano et al.
ANNALS OF SURGERY (2010)
Predictors of Contralateral Breast Cancer in Patients With Unilateral Breast Cancer Undergoing Contralateral Prophylactic Mastectomy
Min Yi et al.
CANCER (2009)
Indications for Sentinel Lymph Node Biopsy in the Setting of Prophylactic Mastectomy
Christine Laronga et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients
Kelly K. Hunt et al.
ANNALS OF SURGERY (2009)
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast - The experience of the European Institute of Oncology on 854 patients in 10 years
Mattia Intra et al.
ANNALS OF SURGERY (2008)
Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
Sarah A. McLaughlin et al.
CANCER (2008)
Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy
Judy C. Boughey et al.
CANCER (2007)
Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment
Todd M. Tuttle et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Detecting occult malignancy in prophylactic mastectomy: Preoperative MRI versus sentinel lymph node biopsy
Dalliah Black et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Selective use of sentinel lymph node surgery during prophylactic mastectomy
Judy C. Boughey et al.
CANCER (2006)
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer:: First results of International Breast Cancer Study Group Trial 10-93
CM Rudenstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An update of sentinel lymph node mapping in patients with ductal carcinoma in situ
C Wilkie et al.
AMERICAN JOURNAL OF SURGERY (2005)
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
KS Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation
B Fisher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer
EA Peralta et al.
AMERICAN JOURNAL OF SURGERY (2000)
The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy
EL Dupont et al.
AMERICAN JOURNAL OF SURGERY (2000)
Share Paper
